Kaiyue Deng

Dr. Kaiyue Deng

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
KDKaiyue Deng
Kaiyue Deng
JCJiazhen Cao
Jiazhen Cao
ZWZitong Wang
Zitong Wang
HJHe jing Jing
He jing Jing
JJJialin Jia
Jialin Jia
TLTie Li
Tie Li
Most patients with irritable bowel syndrome have diarrhea or constipation, two opposite bowel habits. Although defecation habits represent opposing phenotypes, patients across all subtypes exhibit visceral hypersensitivity. This review explores the common pathway that causes visceral hypersensitivity: the mast cell–PAR2–TRP axis. The mechanism involves tryptase released by mast cells. Furthermore, tryptase activates PAR2, which sensitizes downstream TRP ion channels that conduct pain signals. The review also examines the factors leading to the formation of different fecal characteristics. In terms of treatment, this review also summarizes therapeutic agents targeting different components of this axis. Future pharmaceutical research should focus more on the mast cell–PAR2–TRP axis.